Subject has a baseline ATIII level of less than 100% and equal to or above 60%. [clinicaltrials_resource:2f58bebd1db230f2f509bba36eff7e4a]

Subject has a baseline ATIII level of less than 100% and equal to or above 60%. [clinicaltrials_resource:2f58bebd1db230f2f509bba36eff7e4a]